Renal cell carcinoma with central nervous system demyelination caused by nivolumab

INTRODUCTION: Central nervous system demyelination caused by immune checkpoint inhibitors is a very rare condition. CASE PRESENTATION: A 65‐year‐old man who received nivolumab for renal cell carcinoma developed abnormal behavior, such as disagreeable speech and sudden anger. Brain‐enhanced magnetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Toshiki, Yamamoto, Yoshiyuki, Okuda, Yohei, Asakura, Toshihisa, Hatano, Koji, Nakai, Yasutomo, Nakayama, Masashi, Kakimoto, Ken‐ichi, Sugai, Fuminobu, Nishimura, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784733/
https://www.ncbi.nlm.nih.gov/pubmed/33426497
http://dx.doi.org/10.1002/iju5.12234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784733/
https://www.ncbi.nlm.nih.gov/pubmed/33426497
http://dx.doi.org/10.1002/iju5.12234

Ejemplares similares